Abstract:Objectives: To investigate the incidence of vaginal intraepithelial neoplasia (VaIN) after total hysterectomy and, subsequently, optimize the follow-up strategy of patients after hysterectomy. Methods: This retrospective study was conducted on 8581 patients with benign gynecology disease who underwent total hysterectomy in our institution between January 2006 to December 2017, including 834 patients with cervical intraepithelial neoplasia (CIN) and 7747 patients without cervical lesions before hysterectomy. All patients underwent postoperative high-risk human papilloma virus (Hr-HPV) screening and liquid-based cytology test (LCT) as confirmatory tests. Colposcopies were performed if the results of the confirmatory tests were abnormal, and biopsies were performed depending on colposcopy images. The mean follow-up time was 33.8 ± 12.1 months. The relationship among VaIN, CIN, and confirmatory test results was investigated. Results: VaIN was found in 81 patients after hysterectomy (incidence rate, 0.9%). The incidence rates of VaIN in patients with and without CIN history were significantly different (7.3%, 61/834, vs 0.3%, 20/7747; P < 0.05). Compared with patients without CIN history, those with CIN history were more likely to have abnormal LCT results in the postoperative follow-up, especially low-grade squamous intraepithelial lesions or worse (P < 0.001). Patients with high-grade squamous intraepithelial lesions in the LCT have a high VaIN incidence (patients with CIN history, 57.1%; patients without CIN history, 15.1%), and the 2 patients with squamous cell carcinoma or adenocarcinoma (SCC/AC) in the LCT had CIN and VaIN or worse after hysterectomy. The Hr-HPV infection rates after the hysterectomy of patients with and without CIN history were 18.8% (157/834) and 5.4% (419/7747), respectively. The incidences morbidities of VaIN in patients with persistent Hr-HPV infection and in those with and without CIN history were 35.7% and 12.0%, respectively, and were significantly higher than those in patients with negative Hr-HPV (patients with CIN history, 0.7%; patients without CIN history, 0.1%; P = 0.002). The incidence of VaIN in patients with CIN history with HPV-16 infection after hysterectomy was as high as 50%, but in patients without CIN history, the incidences of different Hr-HPV subtypes were not significantly different (P = 0.953). Conclusion: Patients with CIN history were more prone to VaIN and SCC after hysterectomy than were patients without CIN history. Patients should be screened thoroughly for cervical and vaginal lesions before hysterectomy. After hysterectomy, patients with CIN history should undergo lifetime annual LCT and HPV screening.

Risk factors analysis of persistence, progression and recurrence in vaginal intraepithelial neoplasia

Clinical Features, Treatment and Outcomes of Vaginal Intraepithelial Neoplasia in a Chinese Tertiary Centre

Risk Factors for the Development of Vaginal Intraepithelial Neoplasia.

The correlation between vaginal intraepithelial neoplasia and cervical intraepithelial neoplasia, and their risk factors

Advances in diagnosis and treatment of vaginal intraepithelial neoplasia

[Analysis of Diagnosis and Treatment of Vaginal Intraepithelial Neoplasia and Correlation to Cervical Intraepithelial Neoplasia].

Clinical analysis of 56 cases with vaginal intraepithelial neoplasia after hysterectomy

[Preliminary Study of Vulvar and Vaginal Intraepithelial Neoplasias].

A Retrospective Study of 657 Women with Vaginal Intraepithelial Neoplasia (Vain)

Human papillomavirus in vaginal intraepithelial neoplasia

A retrospective study of cytology and HPV genotypes results of 3229 vaginal intraepithelial neoplasia patients

Clinical Characteristics, HPV Involvement, and Demographic Risk Factors in Women with Cervical Intraepithelial Neoplasia Complicated by Vaginal Intraepithelial Neoplasia

Incidence and Risk Factors for Recurrence and Progression of HPV–Independent Vulvar Intraepithelial Neoplasia

Impact of postsurgical vaginal microbiome on high-risk HPV infection and recurrence risk in patients with cervical cancer and intraepithelial neoplasia: A retrospective study

Clinical Characteristics and Risk Factors of Invasion in Extramammary Paget’s Disease of the Vulva

Types and Viral Load of Human Papillomavirus, and Vaginal Microbiota in Vaginal Intraepithelial Neoplasia: a Cross-Sectional Study

Evaluation of Different Treatment Modalities for Vulvar Intraepithelial Neoplasia (VIN): CO2 Laser Vaporization, Photodynamic Therapy, Excision and Vulvectomy

Vaginal intraepithelial neoplasia in patients after total hysterectomy

Research of the potential biomarkers in vaginal microbiome for persistent high-risk human papillomavirus infection.

High-grade vaginal intraepithelial neoplasia and recurrence risk: analysis of an Italian regional referral center series